
Intraocular corticosteroid use at the end of phacoemulsification with IOL implantation is a quick and easy way to deliver the medication and control postoperative inflammation after cataract surgery.
This single-dose intraoperative approach results in fewer postoperative medications that the patient needs to use, thus making it more convenient for the patient and eliminating noncompliance issues.
In this column, Dr. Singh explains the surgical technique of Dexycu (dexamethasone intraocular suspension 9%, EyePoint Pharmaceuticals) drug delivery, allowing consistent placement, easy use and more